H4RT
@h4rt-uk.bsky.social
The High-volume Haemodiafiltration vs High-flux Haemodialysis Registry Trial
An RCT comparing High-volume post-dilution HDF and High-flux HD. North Bristol NHS Trust | University of Bristol | UK Renal Registry
An RCT comparing High-volume post-dilution HDF and High-flux HD. North Bristol NHS Trust | University of Bristol | UK Renal Registry
It's #Red4Research Day, supporting research and all who make research happen. Sunita and Nicola from the central H4RT team are wearing red to thank everyone involved in making H4RT happen!😀
@nihr.bsky.social
@bristoluni.bsky.social
@nicolagiles.bsky.social
@nihr.bsky.social
@bristoluni.bsky.social
@nicolagiles.bsky.social
June 20, 2025 at 11:24 AM
It's #Red4Research Day, supporting research and all who make research happen. Sunita and Nicola from the central H4RT team are wearing red to thank everyone involved in making H4RT happen!😀
@nihr.bsky.social
@bristoluni.bsky.social
@nicolagiles.bsky.social
@nihr.bsky.social
@bristoluni.bsky.social
@nicolagiles.bsky.social
Today is International Clinical Trials Day, when we celebrate the importance of clinical trials in advancing medical knowledge and improving patient outcomes. As always, huge thanks go to our 1553 participants for making H4RT a success 😀
May 20, 2025 at 1:28 PM
Today is International Clinical Trials Day, when we celebrate the importance of clinical trials in advancing medical knowledge and improving patient outcomes. As always, huge thanks go to our 1553 participants for making H4RT a success 😀
Today is #WorldKidneyDay . As always, we are hugely grateful to the amazing 1553 dialysis patients who agreed to take part in H4RT. 🥰
#WorldKidneyDay2025
#WorldKidneyDay2025
March 13, 2025 at 9:18 AM
Today is #WorldKidneyDay . As always, we are hugely grateful to the amazing 1553 dialysis patients who agreed to take part in H4RT. 🥰
#WorldKidneyDay2025
#WorldKidneyDay2025
H4RT is a non-blinded Randomised Controlled Trial comparing the clinical and cost-effectiveness of high-volume HDF compared with high-flux HD in the treatment of end stage kidney disease.
H4RT recruited to target in September 2022 and follow-up will end May 2025.
www.bristol.ac.uk/population-h...
H4RT recruited to target in September 2022 and follow-up will end May 2025.
www.bristol.ac.uk/population-h...
December 4, 2024 at 4:54 PM
H4RT is a non-blinded Randomised Controlled Trial comparing the clinical and cost-effectiveness of high-volume HDF compared with high-flux HD in the treatment of end stage kidney disease.
H4RT recruited to target in September 2022 and follow-up will end May 2025.
www.bristol.ac.uk/population-h...
H4RT recruited to target in September 2022 and follow-up will end May 2025.
www.bristol.ac.uk/population-h...